Asia Pacific Clinical Laboratory Services Market Growth, Size, Trends, Revenue and Future Outlook
Asia-Pacific Clinical Laboratory Services Market Size- By Specialty, By Provider, By Service Type, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Jan-2024 | Report ID: HLCA2408 | Pages: 1 - 157 | Formats*: |
| Category : Healthcare | |||
Asia Pacific Clinical Laboratory Services Market Introduction and Overview
According to SPER Market Research, the Clinical Laboratory Services Market is estimated to reach USD 332.75 Billion by 2033 with a CAGR of 4.4%.
The report includes an in-depth analysis of the Asia Pacific Clinical Laboratory Services Market, including market size and trends, product mix, applications, and supplier analysis. A clinical laboratory's ability to offer a wide range of services, including patient diagnosis, prevention, treatment, and management, makes it indispensable to any given economy's healthcare system. These services help doctors make judgements about patient care and tailor prescriptions to each patient's needs and condition. Clinical laboratory services depend on state-of-the-art equipment and test kits to minimise human error and produce accurate findings. These days, a number of clinics use computers and software to help patients find out about reporting test findings and getting billed for finished exams.
- July 2021, A research collaboration agreement has been established between ARUP Laboratories, a premier U.S. reference laboratory and a global leader in cutting-edge laboratory research and development, and Deep Bio, a pioneer in artificial intelligence (AI) cancer diagnosis. The company has profited from this partnership in terms of using AI to cancer diagnosis.
- September 2021: The Cobas pure integrated solutions analyzer, which has a more sophisticated system and is especially suited for the nation's many labs and hospitals, was introduced by Roche Diagnostics' Indian branch.
Market Opportunities and Challenges
There exists a substantial opportunity for independent laboratories to flourish in densely populated and developing nations such as India and China. In these regions, where a significant portion of the population lacks access to adequate medical diagnostic facilities, independent laboratories can play a crucial role in addressing the extensive gap in clinical service providers. Consequently, there has been a notable rise in the number of independent laboratories. According to the National Accreditation Board for Testing and Calibration Laboratories (NABL) in India, the count of NABL-accredited medical labs increased from around 6,200 in November 2020 to 6,975 by March 2022, driven by the growing demand for such services across the country.
Insufficient diagnostic testing could potentially impede the market's growth during the projected timeframe. The approvals regulatory framework has long been a significant barrier to the rapid expansion of the biotechnology, pharmaceutical, and medical technology sectors. To guarantee accurate and trustworthy test findings, clinical laboratory services are subject to strict rules and quality control procedures. Smaller laboratories may find it costly and time-consuming to comply with these rules, which could limit their market. The clinical laboratory services market is also confronting a scarcity of skilled laboratory personnel, including pathologists, clinical laboratory scientists, and technicians. The lack of qualified workers presents a serious obstacle to the development and expansion of clinical laboratory services.
Market Competitive Landscape
The major key players in the Asia Pacific Clinical Laboratory Services Market are: Abbott (U.S.), ARUP Laboratories (U.S.), Bioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), Fresenius Medical Care AG and Co. KGaA (Germany), Genoptix, Inc. (U.S.), Healthscope (Australia), Laboratory Corporation of America Holdings (U.S.), Merck KGaA (Germany), NeoGenomics Laboratories (U.S.), OPKO Health, Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Sonic Healthcare Limited (Australia), The Laboratory Glassware Co. (U.S.), and Tulip Diagnostics (P) Ltd. (India), Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Specialty, By Provider, By Service Type, By Application |
| Regions covered | Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand and rest of Asia-Pacific |
| Companies Covered | Abbott (U.S.), ARUP Laboratories (U.S.), Bioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), Fresenius Medical Care AG and Co. KGaA (Germany), Genoptix, Inc. (U.S.), Healthscope (Australia), Laboratory Corporation of America Holdings (U.S.), Merck KGaA (Germany), NeoGenomics Laboratories (U.S.), OPKO Health, Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Sonic Healthcare Limited (Australia), The Laboratory Glassware Co. (U.S.), and Tulip Diagnostics (P) Ltd. (India), Others |
COVID-19 Impact on Asia Pacific Clinical Laboratory Services Market
The COVID-19 pandemic has profoundly influenced the clinical laboratory services business. Global demand for COVID-19 testing, including RT-PCR and antigen tests, has increased dramatically, which has caused testing capacities to grow quickly. The testing volume had to be adjusted, new testing techniques had to be implemented, and prompt results reporting had to be made sure of. Clinical laboratories now offer remote testing and result delivery, and the pandemic has hastened the implementation of telehealth and remote monitoring. Moreover, COVID-19 research and development initiatives have sparked partnerships between labs, educational institutions, and pharmaceutical firms, encouraging creativity and the creation of novel diagnostic techniques and treatment plans.
Key Target Audience:
- Healthcare Providers
- Diagnostic Laboratories
- Physicians and Healthcare Professionals
- Pharmaceutical Companies
- Biotechnology Companies
- Health Insurance Providers
- Clinical Research Organizations (CROs)
- Medical Equipment Manufacturers
- Telehealth and Digital Health Companies
- Others
Our in-depth analysis of the Clinical Laboratory Services Market includes the following segments:
| By Specialty: |
|
| By Provider: |
|
| By Service Type: |
|
| By Application: |
|
Key Topics Covered in the Report:
- Asia Pacific Clinical Laboratory Services Market Size (FY’2023-FY’2033)
- Overview of Asia Pacific Clinical Laboratory Services Market
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Specialty (Clinical Chemistry Testing, Cytology Testing and Genetic Testing, Drugs of Abuse Testing, Hematology Testing, Immunology Testing, Microbiology Testing)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Provider (Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories, Independent and Reference Laboratories)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Service Type (Esoteric Services and Anatomic Pathology Services, Routine Testing Services)
- Segmentation of Asia Pacific Clinical Laboratory Services Market By Application (Bioanalytical and Lab Chemistry Services, Cell and Gene Therapy Related Services, Drug Development Related Services, Drug Discovery Related Services, Preclinical and Clinical Trial Related Services, Toxicology Testing Services, Other Clinical Laboratory Services)
- Statistical Snap of Asia Pacific Clinical Laboratory Services Market
- Expansion Analysis of Asia Pacific Clinical Laboratory Services Market
- Problems and Obstacles in Asia Pacific Clinical Laboratory Services Market
- Competitive Landscape in the Asia Pacific Clinical Laboratory Services Market
- Impact of COVID-19 and Demonetization on Asia Pacific Clinical Laboratory Services Market
- Details on Current Investment in Asia Pacific Clinical Laboratory Services Market
- Competitive Analysis of Asia Pacific Clinical Laboratory Services Market
- Prominent Players in the Asia Pacific Clinical Laboratory Services Market
- SWOT Analysis of Asia Pacific Clinical Laboratory Services Market
- Asia Pacific Clinical Laboratory Services Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Asia Pacific Clinical Laboratory Services Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Asia Pacific Clinical Laboratory Services Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia Pacific Clinical Laboratory Services Market
7. Asia Pacific Clinical Laboratory Services Market, By Specialty (USD Million)
7.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Specialty, 2023-20337.2. Clinical Chemistry Testing7.3. Cytology Testing and Genetic Testing7.4. Drugs of Abuse Testing7.5. Hematology Testing7.6. Immunology Testing
7.7. Microbiology Testing
8. Asia Pacific Clinical Laboratory Services Market, By Provider (USD Million)
8.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Provider, 2023-20338.2. Hospital-Based Laboratories and Nursing and Physician Office-Based Laboratories8.3. Independent and Reference Laboratories
9. Asia Pacific Clinical Laboratory Services Market, By Service Type (USD Million)
9.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Service Type, 2023-20339.2. Esoteric Services and Anatomic Pathology Services9.3. Routine Testing Services
10. Asia Pacific Clinical Laboratory Services Market, By Application (USD Million)
10.1. Asia Pacific Clinical Laboratory Services Market Value Share and Forecast, By Application, 2023-203310.2. Bioanalytical and Lab Chemistry Services10.3. Cell and Gene Therapy Related Services10.4. Drug Development Related Services10.5. Drug Discovery Related Services10.6. Preclinical and Clinical Trial Related Services10.7. Toxicology Testing Services10.8. Other Clinical Laboratory Services
11. Asia Pacific Clinical Laboratory Services Market Forecast, 2019-2033 (USD Million)
11.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share
12. Asia Pacific Clinical Laboratory Services Market, By Specialty, 2019-2033 (USD Million)
12.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Specialty (2019-2026)12.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Specialty (2027-2033)
13. Asia Pacific Clinical Laboratory Services Market, By Provider, 2019-2033 (USD Million)
13.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Provider (2019-2026)13.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Provider (2027-2033)
14. Asia Pacific Clinical Laboratory Services Market, By Service Type, 2019-2033 (USD Million)
14.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Service Type (2019-2026)14.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Service Type (2027-2033)
15. Asia Pacific Clinical Laboratory Services Market, By Application, 2019-2033 (USD Million)
15.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Application (2019-2026)15.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Application (2027-2033)
16. Asia Pacific Clinical Laboratory Services Market, By Region, 2019-2033 (USD Million)
16.1. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Region (2019-2026)16.2. Asia Pacific Clinical Laboratory Services Market Size and Market Share By Region (2027-2033)16.3. Australia16.4. China16.5. India16.6. Indonesia16.7. Japan16.8. Malaysia16.9. Philippines16.10. Singapore16.11. South Korea16.12. Thailand16.13. Rest of Asia-Pacific
17. Company Profile
17.1. Abbott17.1.1. Company details17.1.2. Financial outlook17.1.3. Product summary17.1.4. Recent developments17.2. ARUP Laboratories17.2.1. Company details17.2.2. Financial outlook17.2.3. Product summary17.2.4. Recent developments17.3. Bioscientia Healthcare GmbH17.3.1. Company details17.3.2. Financial outlook17.3.3. Product summary17.3.4. Recent developments17.4. Charles River Laboratories17.4.1. Company details17.4.2. Financial outlook17.4.3. Product summary17.4.4. Recent developments17.5. Fresenius Medical Care AG and Co. KGaA17.5.1. Company details17.5.2. Financial outlook17.5.3. Product summary17.5.4. Recent developments17.6. Genoptix, Inc.17.6.1. Company details17.6.2. Financial outlook17.6.3. Product summary17.6.4. Recent developments17.7. Healthscope17.7.1. Company details17.7.2. Financial outlook17.7.3. Product summary17.7.4. Recent developments17.8. Laboratory Corporation of America Holdings17.8.1. Company details17.8.2. Financial outlook17.8.3. Product summary17.8.4. Recent developments17.9. Merck KGaA17.9.1. Company details17.9.2. Financial outlook17.9.3. Product summary17.9.4. Recent developments17.10. NeoGenomics Laboratories17.10.1. Company details17.10.2. Financial outlook17.10.3. Product summary17.10.4. Recent developments17.11. OPKO Health, Inc.17.11.1. Company details17.11.2. Financial outlook17.11.3. Product summary17.11.4. Recent developments17.12. QIAGEN17.12.1. Company details17.12.2. Financial outlook17.12.3. Product summary17.12.4. Recent developments17.13. Quest Diagnostics Incorporated17.13.1. Company details17.13.2. Financial outlook17.13.3. Product summary17.13.4. Recent developments17.14. Siemens Healthcare Private Limited17.14.1. Company details17.14.2. Financial outlook17.14.3. Product summary17.14.4. Recent developments17.15. Sonic Healthcare Limited17.15.1. Company details17.15.2. Financial outlook17.15.3. Product summary17.15.4. Recent developments17.16. The Laboratory Glassware Co.17.16.1. Company details17.16.2. Financial outlook17.16.3. Product summary17.16.4. Recent developments17.17. Tulip Diagnostics (P) Ltd.17.17.1. Company details17.17.2. Financial outlook17.17.3. Product summary17.17.4. Recent developments17.18. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
"The key players in the market include Companies Covered Abbott (U.S.), ARUP Laboratories (U.S.), Bioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), Fresenius Medical Care AG and Co. KGaA (Germany), Genoptix, Inc. (U.S.), Healthscope (Australia), Laboratory Corporation of America Holdings (U.S.), Merck KGaA (Germany), NeoGenomics Laboratories (U.S.), OPKO Health, Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Sonic Healthcare Limited (Australia), The Laboratory Glassware Co. (U.S.), and Tulip Diagnostics (P) Ltd. (India), Others."
The approvals regulatory framework has long been a significant barrier to the rapid expansion of the biotechnology, pharmaceutical, and medical technology sectors.
Asia Pacific Clinical Laboratory Services Market is projected to reach USD 332.75 billion by 2033, growing at a CAGR of 4.4% during the forecast period.
Asia Pacific Clinical Laboratory Services Market size from 2022. The Market is expected to reach USD 332.75 billion by 2033, at a CAGR of4.4% during the forecast period.
Asia Pacific Clinical Laboratory Services Market CAGR of 4.4% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Asia Pacific Clinical Laboratory Services Market size is 332.75 billion from 2023 to 2033.
Asia Pacific Clinical Laboratory Services Market Segment is covered By Specialty, By Provider, By Service Type, By Application.
The Asia-Pacific is anticipated to have the highest market share in the Asia Pacific Clinical Laboratory Services Market .
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
